FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

377360003: Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3699645010 Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3699647019 Drospirenone 3 mg and ethinylestradiol 30 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3699648012 Drospirenone 3 mg and ethinyl estradiol 30 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
46812701000001115 Drospirenone 3mg / Ethinylestradiol 30microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module
60245801000001119 Ethinylestradiol 30microgram / Drospirenone 3mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

15 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing drospirenone false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing drospirenone and ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing estradiol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator value 0.03 false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has basis of strength substance Drospirenone true Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator value 3 false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has basis of strength substance Drospirenone false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator value 3 false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has precise active ingredient Drospirenone false Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator value 30 false Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Plays role Contraceptive therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has precise active ingredient Drospirenone true Inferred relationship Existential restriction modifier 2
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Ethinylestradiol + Drospirenone true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Yasmin tablets (Pilsco Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yasmin tablets (Schering Health Care Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yasmin tablets (CST Pharma Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Lucette 0.03mg/3mg tablets (DE Pharmaceuticals) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet Is pack of False Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Lucette 0.03mg/3mg tablets (Pilsco Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yasmin tablets (Doncaster Pharmaceuticals Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yasmin tablets (Sigma Pharmaceuticals Plc) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet Has VMP True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yasmin tablets (Mawdsley-Brooks & Company Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Lucette 0.03mg/3mg tablets (Gedeon Richter (UK) Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Acondro 0.03mg/3mg tablets (Viatris UK Healthcare Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dretine 0.03mg/3mg tablets (Teva UK Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (J M McGill Ltd) Is a False Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (Colorama Pharmaceuticals Ltd) Is a False Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (Niche Pharma Ltd) Is a False Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (DE Pharmaceuticals) Is a False Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Yiznell 0.03mg/3mg tablets (Lupin (Europe) Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) Is a True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has VMP True Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start